Integra LifeSciences (IART) News
NASDAQ: IARTHealth CareMedical/Dental InstrumentsUSD
13.44+0.03 (+0.22%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IART news summary
We found 4 recent headlines mentioning Integra LifeSciences (IART): 2 in the past week and 3 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, IART is up 0.22% at $13.44. The most recent story, "Integra LifeSciences prices $450M in 9.5% secured notes", was published by Seeking Alpha on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Integra LifeSciences headlines
- Integra LifeSciences prices $450M in 9.5% secured notesSeeking Alpha
- Integra Announces Pricing of Senior Secured NotesIntegra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033 (the “Notes”).…GlobeNewswire
- Friday's ETF with Unusual Volume: HTECThe ROBO Global Healthcare Technology and Innovation ETF is seeing unusually high volume in afternoon trading Friday, with over 454,000 shares traded versus three month average volume of about…NasdaqHTEC, BSX, MRNA, QGEN
- Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?Integra's SurgiMend relaunch could support a broader 2027 recovery, but customer recapture and FDA approval remain key to the upside.NasdaqIART, BDX, ABBV